论文信息 - Long-term treatment outcomes and safety of dupilumab as a therapy for bullous pemphigoid: A multicenter retrospective review. - 字舞流文

Long-term treatment outcomes and safety of dupilumab as a therapy for bullous pemphigoid: A multicenter retrospective review.

Jun Lu | M. Rothe | D. Rosmarin | A. Nichols | S. Cohen | Christine Learned | C. Learned | K. Cunningham | S. Alsukait | Sueheidi Santiago | Kaitlynne N. Cunningham

[1] Chao Ji,et al. Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid , 2021, Frontiers in Immunology.

[2] E. Moreno,et al. Dupilumab: a Review of Present Indications and Uses Out Of Indication. , 2021, Journal of investigational allergology & clinical immunology.

[3] P. Asbell,et al. Ocular surface disease associated with dupilumab treatment for atopic diseases. , 2020, The ocular surface.

[4] B. King,et al. Dupilumab as a Novel Therapy for Bullous Pemphigoid: A Multicenter Case Series. , 2020, Journal of the American Academy of Dermatology.

[5] K. Amber,et al. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management , 2018, Clinical Reviews in Allergy & Immunology.